The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A clinical score (CS) for patients with well-differentiated neuroendocrine tumors (WD NETs) under consideration for peptide receptor radionuclide therapy (PRRT) with Lu 177-dotatate.
 
Satya Das
Honoraria - Medsphere; Targeted Oncology
Speakers' Bureau - Ipsen
 
Liping Du
No Relationships to Disclose
 
Aimee Schad
No Relationships to Disclose
 
Shikha Jain
Stock and Other Ownership Interests - Doximity
Honoraria - Tempus
Consulting or Advisory Role - Healio; Magellan Health
 
Aaron Jessop
No Relationships to Disclose
 
Chirayu Shah
No Relationships to Disclose
 
David Eisner
No Relationships to Disclose
 
Dana Backlund Cardin
Consulting or Advisory Role - Abbvie; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Kristen Keon Ciombor
Consulting or Advisory Role - Array BioPharma; Bayer; Foundation Medicine; Natera; Research to Practice; Research to Practice; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Pfizer/Calithera (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Array BioPharma
 
Laura Williams Goff
Consulting or Advisory Role - Bayer/Onyx; Competitive Drug Development International; Eisai; Lilly; Newlink Genetics; QED Therapeutics
Research Funding - Agios; ArQule; ASLAN Pharmaceuticals; Astellas Pharma; Basilea; BeiGene; Bristol-Myers Squibb; H3 Biomedicine; Incyte; Leap Therapeutics; Lilly; Merck (Inst); Merck (Inst); Onyx; Pfizer; Sun Pharma
 
Marques Bradshaw
No Relationships to Disclose
 
Dominique Delbeke
No Relationships to Disclose
 
Martin P. Sandler
No Relationships to Disclose
 
Jordan Berlin
Consulting or Advisory Role - Abbvie; Bayer Health; Celgene; Clovis Oncology; Cornerstone Pharmaceuticals; EMD Serono; ipsen; qed therapeutics
Research Funding - Abbvie (Inst); Bayer (Inst); boston biomedical (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); I-MAB (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); pfizer (Inst); Pharmacyclics (Inst); PsiOxus Therapeutics (Inst)
Travel, Accommodations, Expenses - Bayer; boston Biomedical; EMD Serono
Other Relationship - novocure; Pancreatic Cancer Action Network